AstraZeneca

ANTIBODY DRUG CONJUGATION STUDY

  • We Advise. When AstraZeneca was considering expanding their laboratory facilities, they called our team to help them decide on a location for an Antibody Drug Conjugation (ADC) laboratory and develop a macro programing document for their executives.
  • We analyzed four locations for them and provided high-level engineering input in the programing phase of the laboratory and utility space design. From an engineering perspective, we had to consider the special requirements that would be needed for radio isotope, bio waste, and chemical waste and make sure that the facility selected could easily accommodate these requirements.
  • Following our survey and analysis, we prepared a macro programming document defining all of the architectural and engineering considerations that needed to be considered to define the scope and budget for the construction of the project.